Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: A population-based cohort study in Taiwan

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Kok, Victor C ^a,b   Horng, Jorng Tzong ^a,c   Lin, Hsin Li ^a   Chen, Yu Ching ^a   Chen, Yan Jun ^c   Cheng, Kuang Fu ^d  

^a ASIA UNIVERSITY   (Taiwan)

^b KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; TAIWAN;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GOUT; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK; TAIWAN;

EID: 84869219070     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-108     Document Type: Article

References (29)

1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Eng J Med 2008, 359(17):1811-1821.
2. Savill P. Gout is an independent risk factor for MI in women. Practitioner 2010, 254(1726):7.
3. Kuo C-F, See L-C, Luo S-F, Ko Y-S, Lin Y-S, Hwang J-S, Lin C-M, Chen H-W, Yu K-H. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology 2010, 49(1):141-146. 10.1093/rheumatology/kep364, 19933595.
4. De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis 2010, 69(6):1162-1164. 10.1136/ard.2009.122770, 3142935, 20124358.
5. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007, 116(8):894-900. 10.1161/CIRCULATIONAHA.107.703389, 17698728.
6. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005, 183(1):147-155. 10.1016/j.atherosclerosis.2005.01.018, 16154134.
7. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 Diabetes as a " Coronary Heart Disease Equivalent" . Diabetes Care 2005, 28(12):2901-2907. 10.2337/diacare.28.12.2901, 16306552.
8. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004, 164(13):1422-1426. 10.1001/archinte.164.13.1422, 15249351.
9. Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE, Manson JE. Diabetes and All-Cause and Coronary Heart Disease Mortality Among US Male Physicians. Arch Intern Med 2001, 161(2):242-247. 10.1001/archinte.161.2.242, 11176738.
10. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE. The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women: 20 Years of Follow-up. Arch Intern Med 2001, 161(14):1717-1723. 10.1001/archinte.161.14.1717, 11485504.
11. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009, 302(16):1782-1789. 10.1001/jama.2009.1488, 19861670.
12. Meisinger C, Doring A, Lowel H. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006, 27(10):1245-1250.
13. Nitsch D, Lawlor DA, Patel R, Carson C, Ebrahim S. The association of renal impairment with all-cause and cardiovascular disease mortality. Nephrol Dial Transplant 2010, 25(4):1191-1199. 10.1093/ndt/gfp607, 19948872.
14. Quinn MP, Cardwell CR, Kee F, Maxwell AP, Savage G, McCarron P, Fogarty DG. The finding of reduced estimated glomerular filtration rate is associated with increased mortality in a large UK population. Nephrol Dial Transplant 2011, 26(3):875-880. 10.1093/ndt/gfq505, 20713975.
15. ICD-9-CM International classification of diseases, 9th revision; clinical modification, 6th edition, Hospital edition edn 2006, Los Angeles: A Practice Management Information Corporation (PMIC), C2005, ICD-9-CM.
16. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005, 20(1):12-19. 10.1016/j.jcrc.2004.09.007, 16015512.
17. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000, 29(5):891-898. 10.1093/ije/29.5.891, 11034974.
18. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB, Savage PJ, Levy D, Fox CS. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009, 119(13):1728-1735. 10.1161/CIRCULATIONAHA.108.829176, 2789419, 19307472.
19. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008, 168(10):1104-1110. 10.1001/archinte.168.10.1104, 18504339.
20. Teng GG, Ang LW, Saag KG, Yu MC, Yuan JM, Koh WP. Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Ann Rheum Dis 2012, 71(6):924-928. 10.1136/ard.2011.200523, 3400339, 22172492.
21. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, Arroyo D, Luno J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010, 5(8):1388-1393. 10.2215/CJN.01580210, 2924417, 20538833.
22. Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, Yamamoto T, Igawa O, Hisatome I, Shigemasa C. Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J 2003, 67(9):781-787. 10.1253/circj.67.781, 12939555.
23. Luk AJ, Levin GP, Moore EE, Zhou XH, Kestenbaum BR, Choi HK. Allopurinol and mortality in hyperuricaemic patients. Rheumatology (Oxford) 2009, 48(7):804-806.
24. Rhoden E, Teloken C, Lucas M, Rhoden C, Mauri M, Zettler C, Bello-Klein A, Barros E. Protective effect of allopurinol in the renal ischemia-reperfusion in uninephrectomized rats. Gen Pharmacol 2000, 35(4):189-193. 10.1016/S0306-3623(01)00105-7, 11827725.
25. Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM. Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol 2011, 71(4):600-607. 10.1111/j.1365-2125.2010.03887.x, 3080649,3080649, 21395653.
26. Yusuf S, Hawken S, Unpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364(9438):937-952. 10.1016/S0140-6736(04)17018-9, 15364185.
27. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies. J Am Coll Cardiol 2007, 49(4):403-414. 10.1016/j.jacc.2006.09.032, 17258085.
28. Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men. JAMA 2002, 288(21):2709-2716. 10.1001/jama.288.21.2709, 12460094.
29. Wen CJ, Lee YS, Lin WY, Huang HL, Yao CA, Sung PK, Huang KC. The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly. Eur J Clin Invest 2008, 38(7):469-475. 10.1111/j.1365-2362.2008.01965.x, 18505405.